Ube2G1 in complex with ubiquitin variant Ubv.G1.1

2-Gaussian fit: Grosse-Kunstleve RW, Sauter NK, Adams PD: Newsletter of the IUCr Commission on Crystallographic Computing 2004, 3, 22-31.

Structural and Functional Analysis of Ubiquitin-based Inhibitors That Target the Backsides of E2 Enzymes.

Cysteine modified with beta-mercaptoethanol

E2 ubiquitin-conjugating enzyme G1,E217K,UBC7,Ubiquitin carrier protein G1,Ubiquitin-protein ligase G1

SMTELQSALLLRRQLAELNKNPVEGFSAGLIDDNDLYRWEVLIIGPPDTLYEGGVFKAHLTFPKDYPLRPPKMKFITEIW
HPNVDKNGDVCISILHEPGEDKYGYEKPEERWLPIHTVETIMISVISMLADPNGDSPANVDAAKEWREDRNGEFKRKVAR
(CME)VRKSQETAFE

SMTELQSALLLRRQLAELNKNPVEGFSAGLIDDNDLYRWEVLIIGPPDTLYEGGVFKAHLTFPKDYPLRPPKMKFITEIW
HPNVDKNGDVCISILHEPGEDKYGYEKPEERWLPIHTVETIMISVISMLADPNGDSPANVDAAKEWREDRNGEFKRKVAR
CVRKSQETAFE

GAGGDYKDDDDKMQIFVKPIRVKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFSGKLLEDGRTLSDYNIQKEYTLH
LLLRRH

25% PEG1500, Succinic acid, Sodium phosphate monobasic monohydrate, Glycine

Canadian Institutes of Health Research (CIHR)

Ubiquitin, Ubiquitin conjugating enzyme, Ubiquitin variant, Ube2G1, TRANSFERASE

MTELQSALLLRRQLAELNKNPVEGFSAGLIDDNDLYRWEVLIIGPPDTLYEGGVFKAHLTFPKDYPLRPPKMKFITEIWH
PNVDKNGDVCISILHEPGEDKYGYEKPEERWLPIHTVETIMISVISMLADPNGDSPANVDAAKEWREDRNGEFKRKVARC
VRKSQETAFE